FindTrial
Sign In

Comparison of 2 drugs in patients undergoing urology surgeries

Evaluation of hyperbaric levobupivacaine and hyperbaric bupivacaine in patients undergoing transurethral endoscopic surgeries - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082743
Enrollment
70
Registered
2025-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N359- Urethral stricture, unspecified

Interventions

Intervention1: Bupivacaine and Levobupivacaine in surgeries: Evaluation of Hyperbaric Bupivacaine and Hyperbaric Levobupivacaine in patients undergoing transurethral endoscopic surgeries

Sponsors

Gandhi Medical College
Lead Sponsor
Rajkumar Ahirwal
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I&II All patients undergoing transurethral endoscopic surgeries

Exclusion criteria

Exclusion criteria: patient with neurological disease spine/neurological deformities local skin infection/disease

Design outcomes

Primary

MeasureTime frame
TO evaluate the effect of hyperbaric bupivacaine on the onset and duration of sensory and motor block to evaluate perioperative hemodynamic effectsTimepoint: TO evaluate the effect of hyperbaric bupivacaine on the onset and duration of sensory and motor block (baseline to after 180 mins of block) to evaluate perioperative hemodynamic effects—

Secondary

MeasureTime frame
to evaluate postoperative analgesia to evaluate the occurrence of side effects & complications if anyTimepoint: Baseline to after 180 mins of block—

Countries

India

Contacts

Public ContactRajkumar Ahirwal

gandhi medical college bhopal

drrajkumarahirwal@ymail.com9826742427

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026